Hiroto Fujigasaki
-
- Genetic Neurodegenerative Diseases 19
- Neurology top 5%
- Neurological disorders and treatments 6
- Parkinson's Disease Mechanisms and Treatments 4
- Neurology top 5%
- Neurological disorders and treatments 6
- Parkinson's Disease Mechanisms and Treatments 4
- Molecular Biology top 10%
- Mitochondrial Function and Pathology 18
- Ubiquitin and proteasome pathways 4
- Prion Diseases and Protein Misfolding 3
- DNA Repair Mechanisms 3
- Clinical Biochemistry top 10%
-
- Cerebrovascular and Carotid Artery Diseases 3
Hiroto Fujigasaki
39 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 66
- Cellular and Molecular Neuroscience 888
- Neurology 380
- Neurology 138
- Molecular Biology 988
- Clinical Biochemistry 42
Countries citing papers authored by Hiroto Fujigasaki
This map shows the geographic impact of Hiroto Fujigasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroto Fujigasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroto Fujigasaki more than expected).
Fields of papers citing papers by Hiroto Fujigasaki
This network shows the impact of papers produced by Hiroto Fujigasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroto Fujigasaki. The network helps show where Hiroto Fujigasaki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroto Fujigasaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 6 | |
| 2 | 2017 | 24 | |
| 3 | 2015 | 12 | |
| 4 | 2015 | 27 | |
| 5 | 2012 | 4 | |
| 6 | 2010 | 5 | |
| 7 | 2009 | 80 | |
| 8 | 2009 | 45 | |
| 9 | 2008 | 1 | |
| 10 | UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase in nuclei and rimmed vacuoles of muscle fibers in DMRV (distal myopathy with rimmed vacuoles). | 2008 | 2 |
| 11 | 2005 | 45 | |
| 12 | 2004 | 46 | |
| 13 | 2004 | 57 | |
| 14 | 2003 | 49 | |
| 15 | 2001 | 68 | |
| 16 | 2001 | 55 | |
| 17 | 2001 | 122 | |
| 18 | 2001 | 26 | |
| 19 | 2000 | 91 | |
| 20 | 1996 | 9 |
About Hiroto Fujigasaki
Hiroto Fujigasaki is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology, having authored 39 papers that have together received 1.3k indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (19 papers), Mitochondrial Function and Pathology (18 papers), Neurological disorders and treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (4 papers), Ubiquitin and proteasome pathways (4 papers), Prion Diseases and Protein Misfolding (3 papers), DNA Repair Mechanisms (3 papers) and Cerebrovascular and Carotid Artery Diseases (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (888 citations), Neurology (380 citations) and Neurology (138 citations). Hiroto Fujigasaki has collaborated with scholars based in Japan, France and United States. Frequent co-authors include Toshiki Uchihara, K Iwabuchi, Ayako Nakamura, Saburo Yagishita, Shigeru Koyano, Alexis Brice, Hidehiro Mizusawa, Kinya Ishikawa, Junko Takahashi‐Fujigasaki and Kimihito Arai. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Brain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.